GLP-1 Medications vs Keto Diet: Which Approach Works Better for Weight Loss?

Sarah had tried keto three times over five years. Each time, she'd lose 20 pounds in the first two months, feel amazing for a while, then gradually slide back into her old eating habits. The weight would return, plus a few extra pounds. When her doctor suggested trying semaglutide instead, she was skeptical—wasn't this just another quick fix? A year later, she's down 52 pounds and eating a normal, balanced diet without the constant mental calculation of carb counts and ketone levels.

The conversation around weight loss has shifted dramatically in the past few years. On one side, you've got the ketogenic diet—a high-fat, very low-carb approach that's been around since the 1920s and gained massive popularity in the last decade. On the other, there's a new class of medications called GLP-1 receptor agonists that are changing how we think about obesity treatment. Both can produce significant weight loss, but they couldn't be more different in how they work, what they require from you, and how sustainable they are long-term.

How Each Approach Actually Works in Your Body

Let's start with keto, because the mechanism is fairly straightforward. When you drastically reduce carbohydrates to typically 20-50 grams per day, your body runs out of its preferred fuel source: glucose. After a few days, your liver starts breaking down fat into molecules called ketones, which your brain and body can use for energy instead. This metabolic state is called ketosis, and it's where the diet gets its name.

The weight loss on keto comes from several factors. First, you lose a significant amount of water weight in the first week—anywhere from 5-10 pounds—because stored carbohydrates (glycogen) bind to water molecules. When you deplete glycogen, that water goes too. Second, ketones have a natural appetite-suppressing effect. Third, the diet is extremely restrictive, which often leads to eating fewer calories overall simply because so many foods are off-limits. Fat and protein are also more satiating than carbohydrates for most people.

GLP-1 medications work on an entirely different level. These drugs—semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound)—mimic a hormone your gut naturally produces after you eat. This hormone does several things: it slows down how quickly food leaves your stomach, it signals to your brain that you're full, it reduces cravings, and it helps regulate blood sugar levels.

The key difference? You're not fighting hunger with willpower on a GLP-1 medication. We see this frequently in our patients—they describe food noise quieting down, being satisfied with smaller portions, and not thinking about their next meal constantly. In the STEP 1 trial, participants on semaglutide lost an average of 14.9% of their body weight over 68 weeks. The SURMOUNT-1 trial showed even more dramatic results with tirzepatide: participants lost up to 22.5% of their body weight.

With keto, you're manually forcing a metabolic change through food restriction. With GLP-1s, you're using pharmacology to work with your body's natural hunger and satiety signals. Both get results, but the experience of being on them feels completely different.

The Reality of Staying Consistent Long-Term

Here's where things get real: most diets fail not because they don't work initially, but because people can't stick with them. The statistics are sobering. Research shows that about 60-70% of people who start a ketogenic diet quit within the first year. The reasons vary—social situations become difficult, the food restrictions feel overwhelming, keto flu symptoms drag on, or people simply miss foods they love.

Keto requires constant vigilance. You're reading every label, calculating net carbs, meal prepping extensively, and often preparing separate meals from your family. Eating out becomes a challenge. You can't just grab something quick when you're busy. One patient told me she felt like she needed a PhD in nutrition just to get through a normal week.

There's also the issue of "falling off the wagon." If you eat a bowl of pasta or a sandwich, you're knocked out of ketosis. It takes several days to get back into that fat-burning state, and during that transition, many people feel terrible—headaches, fatigue, irritability. This all-or-nothing aspect makes keto particularly vulnerable to the cycle of restriction and rebound that Sarah experienced.

GLP-1 medications require a weekly injection (for most formulations), but they don't require you to completely overhaul your diet. You still need to eat healthier and make good choices—the medication isn't magic—but you're not eliminating entire food groups. You can eat a piece of birthday cake at your kid's party without derailing everything. You can have toast with breakfast if you want it.

In our clinical experience, adherence rates with GLP-1 medications are significantly higher in the first year compared to restrictive diets. The main barriers tend to be cost and side effects like nausea, not the behavioral burden of following the plan. That's a huge distinction. One study following patients on semaglutide found that about 70% were still taking it after one year, compared to the roughly 30% still following keto.

Sustainability matters because weight loss that doesn't last isn't really successful. You need an approach you can maintain not just for months, but for years. Both options require long-term commitment—keto as a permanent lifestyle change, and GLP-1s as ongoing medication—but the daily reality of that commitment looks very different.

What the Research Actually Shows About Results

When you look at head-to-head comparisons of weight loss results, GLP-1 medications have the edge in most scenarios. The STEP 1 trial, which involved 1,961 participants, showed that people on semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks. Nearly one-third lost 20% or more of their starting weight. Those are results that rival bariatric surgery for many patients.

Tirzepatide shows even stronger numbers. The SURMOUNT-1 trial demonstrated average weight loss of 15-22.5% depending on the dose, with the highest dose (15 mg) producing the most dramatic results. At the 72-week mark, participants on the highest dose had lost an average of 52 pounds.

Keto studies show more modest results, and they're harder to compare directly because adherence varies so much. A meta-analysis looking at multiple keto diet studies found average weight loss of about 2-8% of body weight over 6-12 months. Some individuals do better—losing 10-15% of their weight—but the average tends to be lower than what we see with GLP-1s. Part of this is because the studies include people who quit or who couldn't stick to the strict carb limits.

There's also the question of what you're losing. Initial keto weight loss includes a lot of water weight. GLP-1 medications produce slower but steadier fat loss. Both approaches can result in some muscle loss along with fat loss, which is why resistance training and adequate protein are essential with either method.

Beyond just the number on the scale, the SELECT trial showed that semaglutide reduced the risk of major cardiovascular events by 20% in people with existing heart disease. That's a significant health benefit that goes well beyond weight loss. We don't have equivalent long-term cardiovascular outcome data for ketogenic diets, though some shorter studies show improvements in certain metabolic markers like triglycerides and HDL cholesterol.

The metabolic improvements are worth noting for both approaches. Keto can significantly improve blood sugar control and insulin sensitivity, especially in the first few months. GLP-1 medications were actually developed for type 2 diabetes before being approved for weight loss, and they're excellent at improving glycemic control. Both can help reduce fatty liver disease, lower blood pressure, and improve cholesterol profiles.

The Cost Factor Nobody Talks About Enough

Money matters, and this is where keto has an advantage—at least on paper. The diet itself doesn't cost anything beyond your regular grocery bill, though many people find that high-quality fats, proteins, and low-carb specialty products can actually increase food costs. You're eating more expensive foods like grass-fed meat, wild-caught fish, nuts, avocados, and specialty keto products. Some people report spending 20-30% more on groceries than they did before.

GLP-1 medications have a reputation for being expensive, and brand-name versions certainly are. Wegovy and Mounjaro can cost $1,000-$1,500 per month without insurance. Many insurance plans don't cover these medications for weight loss, or they have restrictive criteria. That's put them out of reach for millions of people who could benefit.

Here's where compounded versions change the equation. Compounded semaglutide and tirzepatide—made by specialized pharmacies using the same active ingredients—are available for a fraction of the brand-name cost. We're talking $99-$300 per month instead of over $1,000. That's still more than a diet costs, but it's within reach for many more people.

You also need to factor in the hidden costs. With keto, some people invest in blood ketone meters, specialty cookbooks, meal planning services, and expensive supplements to manage side effects. With GLP-1s, you need to account for the medical consultation, ongoing monitoring, and potentially medications to manage side effects like nausea.

There's also an opportunity cost. If you've tried keto multiple times and it hasn't worked long-term, continuing to cycle through restrictive diets can cost you years of progress. Some patients tell us they wish they'd started medication sooner instead of spending another few years struggling with diets that weren't sustainable for them.

What Women Should Know

Women's bodies respond differently to both keto and GLP-1 medications, and there are some specific considerations to keep in mind. Hormonal fluctuations throughout the menstrual cycle can affect ketosis and how you feel on a low-carb diet. Many women report that keto makes their periods irregular, especially in the first few months. Some experience improvements in PCOS symptoms on keto, while others find the diet worsens hormone-related issues.

GLP-1 medications can affect hormonal birth control effectiveness, particularly if you're experiencing vomiting or severe nausea. You'll need to discuss backup contraception with your doctor. Pregnancy is a contraindication for GLP-1 medications—you need to stop them at least two months before trying to conceive. Keto during pregnancy isn't well-studied and generally isn't recommended without medical supervision.

Women also tend to experience stronger GLP-1 side effects in clinical trials, particularly nausea and vomiting. Starting with a lower dose and increasing gradually usually helps. On the flip side, women in menopause often see particularly good results with GLP-1s for weight loss that's been resistant to diet and exercise alone. The medications seem to help overcome the metabolic slowdown that happens with declining estrogen.

What Men Should Know

Men typically enter ketosis faster than women and often report fewer side effects from the adaptation period. The same metabolic factors that make intermittent fasting easier for many men—higher muscle mass, different hormone profiles—also tend to make keto somewhat easier to follow initially. That said, long-term adherence rates aren't dramatically different between genders.

For men with low testosterone, significant weight loss from either approach can actually help increase testosterone levels naturally. We see this frequently—men who lose 10-15% of their body weight often see their testosterone climb 100-200 points without any hormone replacement. GLP-1 medications may have a slight edge here because the weight loss tends to be more substantial.

There's some evidence that men lose weight slightly faster on GLP-1 medications than women, though the difference isn't huge. In the STEP 1 trial, men lost an average of 13.5 kg compared to 12.8 kg for women at the same dose. The cardiovascular benefits shown in the SELECT trial are particularly relevant for men, who face higher baseline risk of heart disease. Losing significant weight in your 40s, 50s, or 60s can substantially reduce your risk of heart attack and stroke in the following decades.

From the Ozari Care Team

We tell our patients that the best weight loss approach is the one you can actually stick with long-term. That sounds simple, but it's true. We've seen people do well on keto, and we've seen people transform their lives with GLP-1 medications. The decision often comes down to your personal relationship with food, your lifestyle, and what's happened when you've tried other approaches in the past. If you've done well on low-carb diets before and genuinely enjoy that way of eating, keto might work for you. But if you've tried multiple restrictive diets and always end up back where you started, GLP-1 medications offer a different path—one that works with your biology instead of requiring constant willpower to override it.

Key Takeaways

• GLP-1 medications produce greater average weight loss (15-22.5%) compared to ketogenic diets (2-8%) in clinical studies, with higher long-term adherence rates
• Keto requires eliminating nearly all carbohydrates and maintaining ketosis daily, while GLP-1s allow flexible eating with reduced hunger and cravings
• Both approaches improve metabolic health markers, but GLP-1s have proven cardiovascular benefits demonstrated in large clinical trials like SELECT
• Compounded semaglutide and tirzepatide starting at $99/month make GLP-1 therapy accessible without the $1,000+ monthly cost of brand-name medications
• The best choice depends on your history with diets, lifestyle factors, and whether you've struggled with diet-based approaches in the past

Frequently Asked Questions

Can I do keto while taking a GLP-1 medication?

Yes, you can combine keto with GLP-1 medications, though most people find they don't need to be that restrictive. The medication significantly reduces appetite, so following an extremely low-carb diet on top of that can make it difficult to eat enough protein and calories. Many of our patients naturally reduce their carb intake because they're less hungry, but they don't need to eliminate carbs entirely to see excellent results. If you do choose to combine them, work closely with your healthcare provider to make sure you're meeting your nutritional needs and not losing weight too rapidly.

How quickly will I see results with each approach?

Keto typically produces faster initial results—you'll see 5-10 pounds drop in the first week, though much of that is water weight. Fat loss on keto averages 1-2 pounds per week after the initial water loss. GLP-1 medications work more gradually, with most people losing 1-2 pounds per week consistently over many months. You'll usually notice appetite reduction within the first week or two of starting a GLP-1, but the weight comes off steadily rather than dramatically at first. By month 6-12, GLP-1 users typically have lost more total weight than keto dieters.

What happens when I stop—will I gain all the weight back?

This is the hard truth: with either approach, stopping means you're at risk of regaining weight if you return to old eating patterns. Studies show that people who discontinue GLP-1 medications regain about two-thirds of the lost weight within a year if they don't maintain lifestyle changes. With keto, most people regain weight when they reintroduce carbohydrates, especially if they go back to a standard American diet. The key with both approaches is viewing them as long-term lifestyle changes, not temporary fixes. Many people stay on GLP-1 medications long-term at a maintenance dose, while successful keto followers often adopt a permanent low-carb way of eating.

Which is better for someone with type 2 diabetes?

Both can dramatically improve blood sugar control, but GLP-1 medications have the advantage of being specifically designed to regulate glucose levels. They're FDA-approved for treating type 2 diabetes and have extensive safety data in diabetic populations. Keto can also lower blood sugar significantly, but it requires careful monitoring because combining it with certain diabetes medications (especially insulin or sulfonylureas) can cause dangerous low blood sugar episodes. If you have diabetes, GLP-1 medications are generally the safer, more predictable option, though some people successfully manage their diabetes with a ketogenic diet under close medical supervision.

Are there people who shouldn't try either approach?

Yes, both have contraindications. GLP-1 medications aren't recommended if you have a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or a history of pancreatitis. They're also not suitable during pregnancy or breastfeeding. Keto isn't recommended for people with certain metabolic disorders, a history of eating disorders, kidney disease, or anyone taking SGLT2 inhibitors for diabetes (due to increased risk of ketoacidosis). People with gallbladder disease, a history of kidney stones, or those who are pregnant or breastfeeding should also avoid keto without medical supervision. Always consult with a healthcare provider before starting either approach to make sure it's safe for your specific situation.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Learn more at ozarihealth.com.